We would like to thank the National Association of Specialty Pharmacy (NASP) for allowing us to present at this year’s Annual Meeting.
Our presentation, Biosimilars: Price, Policy and Outlook, had the following objectives:
- Identify the definition of biosimilars
- Outline the difference between biosimilars and generics
- Describe the FDA’s outlook on biosimilars
- Explain the supportive policy environment being put into place for biosimilars
- Discuss the outlook for biosimilars as interchangeability policies and legislation evolves
For more information regarding Biosimilars, contact us today.